AtriCure Secures FDA Clearance for AtriClip

The FDA has granted 510(k) clearance to AtriCure’s AtriClip PRO2 left atrial appendage exclusion system for the occlusion of the LAA during minimally invasive procedures.

The device features an “ambidextrous locking and trigger-style clip” designed to allow surgeons to focus on the LAA while steering the device.

AtriCure is based in Mason, Ohio and specializes in atrial fibrillation products. — Anisa Jibrell